Who Owns Zevra Therapeutics Stock?
NASDAQ: ZVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 77.55%
- Held by insiders
- 1.26%
- Institutional holders
- 224
- Institutions 77.6%
- Insiders 1.3%
- Public and other 21.2%
Who owns Zevra Therapeutics stock?
Institutional investors own about 77.6% of Zevra Therapeutics's shares, spread across 224 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.26% of ZVRA.
The largest institutional holders are Blackrock Inc. (0.00%), FMR, LLC (0.00%) and Woodline Partners LP (0.00%). Together, the top 10 institutions control 264.5% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their ZVRA positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ZVRA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 5.11M | 0.00% | +14.6% |
| FMR, LLC | 4.92M | 0.00% | +53.0% |
| Woodline Partners LP | 4.79M | 0.00% | +38.7% |
| Vanguard Capital Management LLC | 2.64M | 61.16% | +6.9% |
| Nantahala Capital Management, LLC | 1.80M | 41.66% | -28.7% |
| State Street Corporation | 1.68M | 38.98% | +7.7% |
| Geode Capital Management, LLC | 1.54M | 35.71% | +12.3% |
| Shaw D.E. & Co., Inc. | 1.31M | 30.29% | +54.4% |
| Qube Research & Technologies Ltd | 1.24M | 28.77% | +47.4% |
| Morgan Stanley | 1.20M | 27.90% | +1.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ZVRA
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Contrafund | 2.94M | 68.13% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.90M | 44.03% |
| iShares Trust-iShares Russell 2000 ETF | 1.50M | 34.80% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 679.91K | 15.76% |
| Janus Detroit Street TRT-Janus Henderson Small/Mid Cap Growth Alpha ET | 670.08K | 15.53% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 644.25K | 14.93% |
| Fidelity Contrafund-Fidelity Contrafund K6 | 628.28K | 14.56% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 503.20K | 11.66% |
| iShares Trust-iShares Biotechnology ETF | 434.96K | 10.08% |
| iShares Trust-iShares Russell 2000 Value ETF | 373.11K | 8.65% |
Frequently asked questions
Who is the largest shareholder of Zevra Therapeutics?
Blackrock Inc. is the largest institutional shareholder of ZVRA, owning 0.00% of shares outstanding (5.11M shares) as of its latest 13F filing.
What percentage of Zevra Therapeutics is owned by institutions?
Institutions own about 77.6% of ZVRA shares and 78.5% of the public float.
How much of Zevra Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.26% of ZVRA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.